K, F., J, D., B, S., C, C., I, K., K, S., . . . S, T. (2025). Evaluating whole genome sequencing for rare diseases in newborn screening: Evidence synthesis from a series of systematic reviews. Health technology assessment (Winchester, England), 29(65), 1. https://doi.org/10.3310/DJRF1124
Chicago Style (17th ed.) CitationK, Freeman, et al. "Evaluating Whole Genome Sequencing for Rare Diseases in Newborn Screening: Evidence Synthesis from a Series of Systematic Reviews." Health Technology Assessment (Winchester, England) 29, no. 65 (2025): 1. https://doi.org/10.3310/DJRF1124.
MLA (9th ed.) CitationK, Freeman, et al. "Evaluating Whole Genome Sequencing for Rare Diseases in Newborn Screening: Evidence Synthesis from a Series of Systematic Reviews." Health Technology Assessment (Winchester, England), vol. 29, no. 65, 2025, p. 1, https://doi.org/10.3310/DJRF1124.